Няма интернет връзка — показва се запазената версия на страницата.

Cencora, Inc.

USUSD
← Към Скрийнъра
US:CORLSE:0HF3

Cencora, Inc. (LSE:0HF3) — Other Pharmaceuticals. Брой борси, на които се търгуват акциите на компанията: 2. На тази страница — цена и график, дивиденти, най-големи акционери и история на броя на акциите.

За Компанията

Уебсайт
cencora.com
Сектор
Health Care · Other Pharmaceuticals
Централа
Chesterbrook, United States
Изпълнителен Директор
Steven H. Collis
Служители
44 000
Основана
2001
Акции в Обращение
190.83 млн към 2026-07-31
Свободно Търгуеми Акции
180.25 млн
Пазарна Капитализация
58.98 млрд USD
Инсайдери
4.3%
Институционални Инвеститори
99.63%
Отрасъл (SIC)
Wholesale-Drugs, Proprietaries & Druggists' Sundries
ISIN
US03073E1055
LEI
AI8GXW8LG5WK7E9UD086
Коефициент на Изплащане
17.8%
FCF
4.06 млрд USD
Payout / FCF
12%
Дълг
11.7 млрд USD
2.2 г. FCF
Дивидентна История
25 г.
Печалба, FCF и изплатени дивиденти — за 12-те месеца до 30.06.2026 (последният отчет на компанията).
Описание

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

реклама

Борси и Тикери

БорсаТикерВалутаЦенаВид
US USA StocksCOR основенUSD325.06 +0.37%обикновени акции
LSE London Stock Exchange0HF3 IOBUSD304.73 +0.00%обикновени акции

Цена за 3 Месеца

ден на ръст ден на спад екс-дата на дивидента дата на изплащанеПосочете / докоснете ден — цени на отваряне, затваряне, най-висока и най-ниска

Дивиденти

Годишно US:COR: 2.4 USD (4 плащ.)

Cencora, Inc. (COR) изплаща дивиденти на тримесечие. Годишно (12 месеца до и включително най-скорошното обявено плащане): 2.4 USD на акция (плащания: 4). Това е около 0.74% от текущата цена на акцията. Според историята на плащанията следващата екс-дивидентна дата се очаква около 13.11.2026. Години непрекъснати дивиденти: 25.

Екс-ДатаИзплащанеСума%ВидТикер
2026-08-142026-08-310.6000 USD0.2/0.8 %тримесечноUS:COR
2026-05-152026-06-010.6000 USD0.2/0.9 %тримесечноUS:COR
2026-02-132026-03-020.6000 USD0.2/0.7 %тримесечноUS:COR
2025-11-142025-12-010.6000 USD0.2/0.6 %тримесечноUS:COR
2025-08-152025-09-030.5500 USD0.2/0.7 %тримесечноUS:COR
2025-05-162025-06-020.5500 USD0.2/0.8 %тримесечноUS:COR
2025-02-142025-03-030.5500 USD0.2/0.9 %тримесечноUS:COR
2024-11-152024-11-290.5500 USD0.2/0.9 %тримесечноUS:COR
2024-08-092024-08-260.5100 USD0.2/≈0.6 %тримесечноUS:COR
2024-05-092024-05-240.5100 USD0.2/≈0.6 %тримесечноUS:COR
2024-02-082024-02-260.5100 USD0.2/≈0.6 %тримесечноUS:COR

Най-Големи Притежатели

ПритежателДялАкцииДата на Доклада
BlackRock9.54%18.21 млн2026-06-30
Vanguard Capital Managem…6.49%12.38 млн2026-06-30
Vanguard Portfolio Manag…5.04%9.61 млн2026-06-30
State Street Corporation4.86%9.27 млн2026-06-30
T. Rowe Price Investment…3.88%7.41 млн2026-06-30
Price (T.Rowe) Associate…3.74%7.13 млн2026-06-30
JPMORGAN CHASE & CO3.11%5.94 млн2026-06-30
VANGUARD INDEX FUNDS-Van…3.07%5.87 млн2026-06-30
Geode Capital Management…2.86%5.45 млн2026-06-30
VANGUARD INDEX FUNDS-Van…2.64%5.04 млн2026-06-30
Boston Partners2.55%4.87 млн2026-06-30
Wellington Management Gr…2.39%4.56 млн2026-06-30
T. ROWE PRICE CAPITAL AP…2.33%4.44 млн2026-06-30
VANGUARD INDEX FUNDS-Van…2.1%4.01 млн2026-06-30
VANGUARD SPECIALIZED FUN…1.59%3.03 млн2026-07-31
iShares Trust-iShares Co…1.36%2.59 млн2026-08-31
Fidelity Concord Street…1.32%2.52 млн2026-07-31
SPDR S&P 500 ETF TRUST-S…1.25%2.38 млн2026-08-31
VANGUARD INDEX FUNDS-Van…0.92%1.76 млн2026-06-30
-Price (T.Rowe) U.S. Val…0.85%1.62 млн2026-06-30
COLLIS STEVEN HOWARD (Of…≈0.16%305 9132025-09-16
CLEARY JAMES F. JR. (Chi…≈0.08%160 3572026-03-11
MAUCH ROBERT P. (Chief E…≈0.03%65 3932026-02-20
DURCAN DERMOT MARK (Dire…≈0.02%31 7672026-06-18
BATTAGLIA SILVANA (Offic…≈0.01%23 6242026-06-30
CAMPBELL ELIZABETH S (Of…≈0.01%19 4552026-08-24
GREENBERG LON R (Directo…≈0.01%17 1282026-09-16
KRIKORIAN LAZARUS (Offic…≈0.01%16 1692026-09-01
NALLY DENNIS M (Director…≈0.01%13 1882026-07-31
The Vanguard Group———
Walgreens Boots Alliance…——2025-02-06